Skip to main content

NY Talc Trial, J&J Hit With $300M In Punitive Damages

NY Talc Trial, J&J Hit With $300M In Punitive Damages

NY Talc Trial, J&J Hit With $300M In Punitive Damages

Introduction

J&J has been hit with $300M in punitive damages over a talcum powder lawsuit, on Friday, following a recent verdict held in NY.

A 66-year old woman and her husband had filed a lawsuit against J&J for her pleural mesothelioma, a cancer of the lining of the lungs in 2017. On May 21, 2019, a New York jury granted $25 million in compensatory damages to the plaintiffs, claiming the company was responsible for her mesothelioma but did not finalize on the punitive damages against the company. The NY jury finalized $300 million in punitive damages on Friday, adding the total verdict to $325 million. According to a J&J spokesperson, the company will appeal against the verdict.

J&J is facing nearly 14,000 similar allegations against its talc-based products. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!